Optiver Holding
BOLD

Optiver Holding’s Boundless Bio BOLD Stock Holding History

Optiver Holding’s Portfolio BOLD Stock Details BOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-168
Closed -$185 – 3142
2026
Q1 		$185 Hold
168
– – ﹤0.01% 2222
2025
Q4 		$202 Hold
168
– – ﹤0.01% 2350
2025
Q3 		$207 Buy
+168
New +$194 ﹤0.01% 2580

Other funds holding BOLD

AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return

Optiver Holding's BOLD Position: Q2 2026 in Review

Optiver Holding sold out of Boundless Bio (BOLD) in Q2 2026, closing a stake of 168 shares — an estimated $185 sold.

Optiver Holding first reported a position in BOLD in Q3 2025 and held it in 3 quarters. The position peaked at $207 in Q3 2025. 40 funds tracked by Wall St. Rank hold BOLD as of Q2 2026.

  • Optiver Holding reported no remaining Boundless Bio position as of Q2 2026 after selling out during the quarter.
  • Optiver Holding sold 168 Boundless Bio shares in Q2 2026, an estimated $185.
  • Optiver Holding first reported a position in Boundless Bio in Q3 2025 and held it in 3 quarters.
  • Optiver Holding's Boundless Bio position peaked at $207 in Q3 2025.
  • 40 funds tracked by Wall St. Rank held Boundless Bio as of Q2 2026.

Based on Optiver Holding's 13F filing for Q2 2026, filed 12 Aug 2026.